A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy

by Ballmer Andrea, Brady Benjamin, Clingan Philip R, Kefford Richard F, Morganti Adele, Hersey Peter
Published 2010-03-01

The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16^INK4a

by Mann Graham J, Reisman David N, Scolyer Richard A, Diefenbach Eve, Frausto Monika, Scurr Lyndee L, Dijkstra Menno K, Haferkamp Sebastian, Becker Therese M, Kefford Richard F, Rizos Helen
Published 2009-01-01